Drug Approval | April 02, 2026
Marksans Pharma receives USFDA approval for Benzonatate capsules
Benzonatate is a non-narcotic antitussive that numbs stretch receptors in the respiratory tract
Benzonatate is a non-narcotic antitussive that numbs stretch receptors in the respiratory tract
The new regimen, delivering 50 mg/5 mL and 28 mg/5 mL doses, offers a higher concentration of the drug for both loading and maintenance phases
The company’s broader OX2R portfolio includes clinical and preclinical assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
Lonza will take on technology transfer, process optimization, and cGMP manufacturing, leveraging its global network and expertise in highly potent compounds
The investigational new drug application with FDA was actually for NEOK002, an EGFR/MUC1-targeting antibody-drug conjugate aimed at solid tumors
Paroxetine extended-release tablets are indicated for the treatment of major depressive disorder
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
TERN-701, a next-generation therapy targeting chronic myeloid leukemia (CML), a form of blood cancer that still presents treatment challenges despite decades of advances
Alkem’s semaglutide comes in a pre-filled disposable injection pen containing four doses for a month, priced at Rs. 1,800
Subscribe To Our Newsletter & Stay Updated
